Home Five Prime Therapeutics

Five Prime Therapeutics

acquired
Post-IPO Round
Biological New Drug Developer

Basic Information

Five Prime Therapeutics is a biotechnology company dedicated to the discovery and development of novel immuno-oncology protein therapies. By systematically screening all relevant proteins in the human body, the company discovers and develops new therapeutic proteins and antibodies to identify the best proteins for treating specific clinical indications. Five Prime's ProScreen platform is capable of rapidly producing and screening all therapeutically relevant proteins with the highest standards of medical quality.
Five Prime Therapeutics, Inc.
SanFrancisco,California,United States of America
51~100 people
January 01, 2002
business.development@fiveprime.com